MedPath

A study to assess the effectiveness of cold compress on relieving the symptoms of allergic conjunctivitis among children of age group 5 – 15 years, residing in Dadu Majra Colony,UT,Chandigarh, 2013-2015.

Completed
Conditions
Other acute conjunctivitis,
Registration Number
CTRI/2016/02/006586
Lead Sponsor
Self financed
Brief Summary

This is a randomized control  trial to asses the effectiveness of cold compress on relieving the symptoms of allergic conjunctivitis being conducted in community setting. Total 217 subjects of age group 5-15 years were selected and randomly allocated to experimental and control group. The primary outcome is the reduction in the severity of the symptoms of allergic conjunctivitis to below 3 on 1-10 scale

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
217
Inclusion Criteria

Children of age group 5-15 yrs ; presenting with any two of the following symptoms – itching, ropy discharge, frequent eye rubbing ; along with redness or watering of eyes for minimum of 1 weeks.

Exclusion Criteria

Children having any eye injury.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
decrease in the intensity of the symptoms of allergic conjunctivitis in the experimental groupdecrease in the intensity of the symptoms of allergic conjunctivitis to less than 3 on severity scale from 0 to 10 on 6th day (post interventional assessment) in the experimental group
Secondary Outcome Measures
NameTimeMethod
decrease in the intensity of the symptoms of allergic conjunctivitis in the experimental groupdaily decrease in the intensity of the symptoms of allergic conjunctivitis on scale from 0 to 10 assessed for 6 days in the experimental group

Trial Locations

Locations (1)

Home visits

🇮🇳

Chandigarh, CHANDIGARH, India

Home visits
🇮🇳Chandigarh, CHANDIGARH, India
Payal Kahol
Principal investigator
07837713102
palukahol@rediffmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.